Seguir
Christopher N Floyd MA, MBBS, PhD, MRCP, FHEA
Christopher N Floyd MA, MBBS, PhD, MRCP, FHEA
NIHR Clinical Lecturer, King's College London
Email confirmado em kcl.ac.uk
Título
Citado por
Citado por
Ano
Mechanisms of aspirin resistance
CN Floyd, A Ferro
Pharmacology & therapeutics 141 (1), 69-78, 2014
2282014
Hypertension in adults: summary of updated NICE guidance
RJ Boffa, M Constanti, CN Floyd, AS Wierzbicki
Bmj 367, 2019
1132019
Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications
CN Floyd, G Passacquale, A Ferro
Clinical pharmacokinetics 51, 429-442, 2012
842012
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis
CN Floyd, BH Ellis, A Ferro
PLoS One 9 (7), e100239, 2014
592014
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis
CN Floyd, A Mustafa, A Ferro
PLoS One 9 (7), e101518, 2014
572014
Antiplatelet drug resistance: Molecular insights and clinical implications
CN Floyd, A Ferro
Prostaglandins & other lipid mediators 120, 21-27, 2015
492015
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
EF Magavern, JC Kaski, RM Turner, H Drexel, A Janmohamed, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (1), 85-99, 2022
452022
Indications for anticoagulant and antiplatelet combined therapy
CN Floyd, A Ferro
BMJ 359, 2017
392017
The PlA1/A 2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta‐analysis
CN Floyd, A Ferro
British journal of clinical pharmacology 77 (3), 446-457, 2014
392014
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin‐resistant but not aspirin‐sensitive subjects
CN Floyd, T Goodman, S Becker, N Chen, A Mustafa, E Schofield, ...
British journal of clinical pharmacology 78 (2), 320-328, 2014
352014
Cost-effectiveness of initiating pharmacological treatment in stage one hypertension based on 10-year cardiovascular disease risk: a Markov modeling study
M Constanti, CN Floyd, M Glover, R Boffa, AS Wierzbicki, RJ McManus
Hypertension 77 (2), 682-691, 2021
252021
Options for the diagnosis of high blood pressure in primary care: a systematic review and economic model
M Constanti, R Boffa, CN Floyd, AS Wierzbicki, RJ McManus, M Glover
Journal of human hypertension 35 (5), 455-461, 2021
232021
Opioids out of control
CN Floyd, JB Warren
British Journal of Clinical Pharmacology 84 (5), 813, 2017
192017
Impact of therapeutic inertia on long-term blood pressure control: a Monte Carlo simulation study
A Augustin, L Coutts, L Zanisi, AS Wierzbicki, F Shankar, PJ Chowienczyk, ...
Hypertension 77 (4), 1350-1359, 2021
182021
Dual antiplatelet therapy in coronary artery disease: comparison between ACC/AHA 2016 and ESC 2017 guidelines
CN Floyd
European Cardiology Review 15, e08, 2020
152020
Antiplatelet therapy as a modulator of stroke aetiology: a meta‐analysis
CA Rajkumar, CN Floyd, A Ferro
British Journal of Clinical Pharmacology 80 (3), 331-341, 2015
152015
Grapefruit juice enhances the systolic blood pressure‐lowering effects of dietary nitrate‐containing beetroot juice
K O'Gallagher, S Borg Cardona, C Hill, A Al‐Saedi, F Shahed, CN Floyd, ...
British journal of clinical pharmacology 87 (2), 577-587, 2021
142021
Acute interaction between oral glucose (75 g as Lucozade) and inorganic nitrate: Decreased insulin clearance, but lack of blood pressure‐lowering
CN Floyd, S Lidder, J Hunt, SA Omar, K McNeill, AJ Webb
British journal of clinical pharmacology 85 (7), 1443-1453, 2019
142019
Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability
CN Floyd, DM Wood, PI Dargan
European journal of clinical pharmacology 74, 349-356, 2018
132018
Acute blood pressure-lowering effects of nitrogen dioxide exposure from domestic gas cooking via elevation of plasma nitrite concentration in healthy individuals
CN Floyd, F Shahed, F Ukah, K McNeill, K O’Gallagher, CE Mills, ...
Circulation Research 127 (6), 847-848, 2020
102020
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20